Show simple item record

dc.contributor.authorNeniskyte, Urteen
dc.contributor.authorFricker, Michaelen
dc.contributor.authorBrown, Guyen
dc.date.accessioned2016-07-04T14:14:13Z
dc.date.available2016-07-04T14:14:13Z
dc.date.issued2016-06-05en
dc.identifier.issn1357-2725
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/256592
dc.description.abstractAlzheimer’s disease is characterized by brain plaques of amyloid beta and by neuronal loss, but it is unclear how amyloid beta causes neuronal loss and how to prevent this loss. We have previously shown that amyloid beta causes neuronal loss by inducing microglia to phagocytose neurons, and here we investigated whether protein kinase Cs and NADPH oxidase were involved in this. The loss of neurons induced by amyloid beta in co-cultures of primary glia and neurons was completely prevented by inhibiting protein kinase Cs with Gö6976 or Gö6983. Directly activating protein kinase Cs with phorbol myristate acetate stimulated microglial phagocytosis, and induced neuronal loss mediated by MFG-E8/vitronectin receptor pathway of microglial phagocytosis. Blocking phagocytosis by MFG-E8 knockout or receptor inhibition left live neurons, indicating microglial phagocytosis was the cause of neuronal death. Phorbol myristate acetate stimulated the microglial NADPH oxidase, and inhibiting the oxidase prevented neuronal loss. A physiological activator of NADPH oxidase, fMLP, also induced neuronal loss dependent on microglia. Amyloid beta-induced neuronal loss was blocked by NADPH oxidase inhibitors, superoxide dismutase or Toll-like receptor function-blocking antibodies. The results indicate that amyloid beta induces microglial phagocytosis of neurons via activating protein kinase Cs and NADPH oxidase, and that activating the kinases or oxidase is sufficient to induce neuronal loss by microglial phagocytosis. Thus inhibiting protein kinase Cs or NADPH oxidase might be beneficial in Alzheimer’s disease or other brain pathologies involving inflammatory neuronal loss mediated by microglia.
dc.description.sponsorshipThis work was partially supported by the Medical Research Council UK (MR/L010593). UN was supported by St John’s College (University of Cambridge), Department of Biochemistry (University of Cambridge) and the Cambridge Trust.
dc.languageEnglishen
dc.language.isoenen
dc.publisherElsevier
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internationalen
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internationalen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/en
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/en
dc.subjectneuroinflammationen
dc.subjectphagoptosisen
dc.subjectphagocytosisen
dc.subjectmicrogliaen
dc.subjectneurodegenerationen
dc.titleAmyloid $\beta$ induces microglia to phagocytose neurons via activation of protein kinase Cs and NADPH oxidaseen
dc.typeArticle
dc.description.versionThis is the author accepted manuscript. The final version is available from Elsevier via http://dx.doi.org/10.1016/j.biocel.2016.06.005en
prism.endingPage355
prism.publicationDate2016en
prism.publicationNameInternational Journal of Biochemistry and Cell Biologyen
prism.startingPage346
prism.volume81en
dc.identifier.doi10.17863/CAM.530
dcterms.dateAccepted2016-06-03en
rioxxterms.versionofrecord10.1016/j.biocel.2016.06.005en
rioxxterms.versionAMen
rioxxterms.licenseref.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/en
rioxxterms.licenseref.startdate2016-06-05en
dc.contributor.orcidBrown, Guy [0000-0002-3610-1730]
dc.identifier.eissn1878-5875
rioxxterms.typeJournal Article/Reviewen
pubs.funder-project-idMRC (MR/L010593/1)
rioxxterms.freetoread.startdate2017-06-05


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 International
Except where otherwise noted, this item's licence is described as Attribution-NonCommercial-NoDerivatives 4.0 International